papillary thyroid cancer glp-1 Glucagon-like peptide 1 receptor agonist use and risk of cancer: Scandinavian cohort study Is a 44‑year‑old woman with

*All sales are FINAL, so please ensure you've selected the correct version before purchase

Nonalcoholic steatohepatitis (NASH), as a severe form of nonalcoholic fatty liver disease (NAFLD), is characterized by liver steatosis, inflammation, hepatocellular injury and different degrees of fibrosis

Nourish oral microbiome, digestive, and gut health with Boost Synergy GLP-1 Probiotic featuring Akkermansia muciniphila

When you eat less, you often consume less fiber, fewer prebiotics, and fewer of the nutrients that keep your digestive tract and beneficial gut bacteria in good shape

The findings of a new study suggest that an apparent association between GLP-1 medications and thyroid cancer may be due to more intensive patient screening, and not a side effect of the drugs themselves.

Discover the different GLP-1 medications available and their potential benefits for weight management.